共 50 条
Real-world prognostic value of RET fusions in advanced non-small cell lung cancer (aNSCLC)
被引:0
|作者:
Gadgeel, S. M.
[1
]
Zhang, Q.
[2
]
Lin, H.
[3
]
Fajardo, O.
[4
]
Trinh, H.
[5
]
Arndorfer, S.
[6
]
Kong, S.
[7
]
Rahman, A.
[8
]
Li, S.
[9
]
Archer, V. R.
[10
]
Gainor, J. F.
[11
]
机构:
[1] Henry Ford Hlth Syst, Dept Internal Med, Henry Ford Canc Inst, Detroit, MI USA
[2] Genentech Inc, Product Dev Data Sci, San Francisco, CA USA
[3] Roche Holding Ltd, Roche Product Dev Shanghai, Shanghai, CA, Peoples R China
[4] F Hoffmann La Roche Ltd, Product Dev Data Sci, Basel, Switzerland
[5] Genentech Inc, Product Dev Real World Data Sci, San Francisco, CA USA
[6] Genesis Res, Real World Evidence, Hoboken, NJ USA
[7] Genentech Inc, Biostat, San Francisco, CA USA
[8] Roche Prod Ltd, Product Dev Clin Dev, Welwyn Garden City, Herts, England
[9] Genentech Inc, Product Dev Oncol, San Francisco, CA USA
[10] Roche Prod Ltd, PDC, Welwyn Garden City, Herts, England
[11] Massachusetts Gen Hosp, Ctr Thorac Cancers, Dept Med, Canc Ctr, Boston, MA USA
关键词:
D O I:
10.1016/j.annonc.2023.09.2421
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
1388P
引用
收藏
页数:2
相关论文